Pharmaco - Press Releases

Date	Title	Company
26-Nov-2019	ERYTECH Announces Publication of its Phase 2b Trial of Eryaspase in Metastatic Pancreatic Cancer in the European Journal of Cancer	ERYTECH
26-Nov-2019	Data on Tepotinib for metastatic non–small cell lung cancer presented at ESMO Asia 2019	Merck
26-Nov-2019	Novartis to acquire The Medicines Company for USD 9.7 bn, adding inclisiran, a potentially transformational investigational cholesterol-lowering therapy to address leading global cause of death	Novartis
26-Nov-2019	Omega Healthcare to Expand Through Tech-enabled Services With Appointment of Sumit Sachdeva as Chief Growth Officer	Omega Healthcare
26-Nov-2019	The 13th Edition of CPhI & P-MEC India Expo Leads the Transformation in the Global Pharmaceutical Space	Informa Markets in India
26-Nov-2019	Data on Acthar® Gel (Repository Corticotropin Injection) Therapy in Symptomatic Sarcoidosis Published in Therapeutic Advances in Respiratory Disease	Mallinckrodt plc
26-Nov-2019	Xlife Sciences AG: New project in the portfolio	Xlife Sciences AG
26-Nov-2019	Camurus Announces New Study Results Showing Superior Patient Reported Outcomes With Buvidal® Versus Standard of Care in Treatment of Opioid Dependence	Camurus AB
25-Nov-2019	Guerbet To Showcase the New Dose&Care® and other Digital Solutions with Diagnostic and Interventional Imaging Offerings at RSNA 2019	Guerbet LLC USA
25-Nov-2019	FDA approves novel treatment to target abnormality in sickle cell disease	U.S. Food and Drug Administration
25-Nov-2019	Clinerion partners with Eugen to expand Patient Network Explorer coverage to patients and hospitals in Uruguay.	Clinerion Ltd.
25-Nov-2019	Xlife Sciences AG: Xlife Sciences AG: Xlife Sciences AG issues convertible bonds	Xlife Sciences AG
25-Nov-2019	INHIBITOR Therapeutics Submits Investigational New Drug Application for Treatment of Patients with Late-Stage Prostate Cancer	INHIBITOR Therapeutics, Inc.
25-Nov-2019	DiaMonTech AG: DAK-Gesundheit and DiaMonTech plan strategic cooperation in the non-invasive blood glucose monitoring sector for new treatment strategies in the diabetes sector	DiaMonTech AG
25-Nov-2019	Vaccitech Provides Update on Clinical Progress for its Two Phase 2 Universal Influenza Studies	B3C newswire
25-Nov-2019	Vaccitech Provides Update on Clinical Progress for its Two Phase 2 Universal Influenza Studies	B3C newswire
25-Nov-2019	Xlife Sciences AG: FUSE-AI, a project company of Xlife Sciences AG enters cooperation agreement with Aarau Cantonal Hospital	Xlife Sciences AG
25-Nov-2019	Newron Receives Second Tranche from Financing Agreement with European Investment Bank (EIB)	Newron Pharmaceuticals S.p.A.
24-Nov-2019	Positive Interim Efficacy Data from GDC-0084 Phase II Study in Glioblastoma Released at SNO Conference	Kazia Therapeutics Limited
24-Nov-2019	DNAtrix Presents Positive Results from the Phase 2 CAPTIVE/KEYNOTE-192 Study of DNX-2401 in Combination with Pembrolizumab for Glioblastoma at the 2019 SNO Annual Meeting	DNAtrix, Inc.